Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Lear Corp (NYSE: LEA) weakened during the last several trading days. LEA’s current Value Trend Rating is D and the […]
Conocophillips (NYSE: COP) has reported E.P.S. of $1.90 for its fourth fiscal quarter (ending December 31) versus $2.53 for the same period a year ago — a decline of -25%. For the latest four quarters […]
Nevro Corp (NYSE: NVRO) stock closed at $5.72 on 2/6/25 after a major increase of 13.9%. Moreover, exceptionally high trading volume at 1696% of normal accompanied the advance. The stock has been extremely weak relative […]
For its fourth fiscal quarter (ending December 31), AptarGroup Inc. (NYSE: ATR) has reported a 60% increase in E.P.S. from $0.95 a year ago to $1.52 in the current quarter. For the latest four quarters […]
AMCON Distributing Co (NYSEAMERICAN: DIT) stock closed at $149.10 on 2/6/25 after a major increase of 15.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 1036% of normal. The stock has risen […]
MDU Resources Group Inc. (NYSE: MDU) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.35 versus $0.84 for the same period a year ago — a decline of -58%. For the […]
Huntington Ingalls Industries In (NYSE: HII) has reported E.P.S. of $3.15 for its fourth fiscal quarter (ending December 31) versus $6.90 for the same period a year ago — a decline of -54%. For the […]
On 2/6/25, Hologic Inc (NASDAQ: HOLX) stock suffered a major decline of -10.1%, closing at $65.45. Moreover, trading volume in this decline was exceptionally high at 327% of normal. The stock has performed in line […]
Haemonetics Corp (NYSE: HAE) has reported earnings for its third fiscal quarter (ending December 31) of $0.75 versus $0.62 for the same period a year ago — an increase of 21%. For the latest four […]
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock suffered a major decline of -15.1% on 2/6/25. The shares closed at $6.62. Moreover, trading volume in this decline was unusually high at 197% of normal. The stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research